4LWU
The 1.14A Crystal Structure of Humanized Xenopus MDM2 with RO5499252
4LWU の概要
| エントリーDOI | 10.2210/pdb4lwu/pdb |
| 関連するPDBエントリー | 4LWT 4LWV |
| 分子名称 | E3 ubiquitin-protein ligase Mdm2, (2'S,3R,4'S,5'R)-N-(4-carbamoylphenyl)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide, SULFATE ION, ... (4 entities in total) |
| 機能のキーワード | mdm2, spiroindolinone, e3 ubiquitin ligase, p53, nucleus, ligase-ligase inhibitor complex, ligase/ligase inhibitor |
| 由来する生物種 | Xenopus laevis (clawed frog,common platanna,platanna) |
| 細胞内の位置 | Nucleus, nucleoplasm (By similarity): P56273 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 10510.96 |
| 構造登録者 | |
| 主引用文献 | Zhang, Z.,Ding, Q.,Liu, J.J.,Zhang, J.,Jiang, N.,Chu, X.J.,Bartkovitz, D.,Luk, K.C.,Janson, C.,Tovar, C.,Filipovic, Z.M.,Higgins, B.,Glenn, K.,Packman, K.,Vassilev, L.T.,Graves, B. Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy. Bioorg.Med.Chem., 22:4001-4009, 2014 Cited by PubMed Abstract: The field of small-molecule inhibitors of protein-protein interactions is rapidly advancing and the specific area of inhibitors of the p53/MDM2 interaction is a prime example. Several groups have published on this topic and multiple compounds are in various stages of clinical development. Building on the strength of the discovery of RG7112, a Nutlin imidazoline-based compound, and RG7388, a pyrrolidine-based compound, we have developed additional scaffolds that provide opportunities for future development. Here, we report the discovery and optimization of a highly potent and selective series of spiroindolinone small-molecule MDM2 inhibitors, culminating in RO8994. PubMed: 24997575DOI: 10.1016/j.bmc.2014.05.072 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.14 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






